Press release
Keratoconus Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - Glaukos Corporation, iVeena Delivery Systems, Inc., Cxlusa, Laboratoires Thea
DelveInsight's "Keratoconus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Keratoconus market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Keratoconus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Keratoconus Market Insights https://www.delveinsight.com/report-store/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Keratoconus Overview
Keratoconus (KC) is an eye (ocular) disorder characterized by progressive thinning and changes in the shape of the cornea. The cornea is the thin, clear outer layer of the eye and is normally dome-shaped. Slowly progressive thinning of the cornea causes a cone-shaped bulge to develop towards the center of the cornea in the areas of greatest thinning.
Some of the key facts of the Keratoconus Market Report:
• The Keratoconus market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In August 2022, iVeena entered into a strategic licensing agreement with Glaukos Corporation that grants Glaukos an exclusive global license to develop and commercialize IVMED-80 for Keratoconus.
• In September 2022, CXL Opthhalmics presented its Phase II data and according to the data 80% of patients maintained or improved corrected distance visual acuity 12 months post-operation and 89%of patients 21 years or younger showed stable or improved vision at12 months
• According to NORD, in the United States indicated a prevalence of keratoconus 54.5 per 100,000 individuals in the general population, or approximately 1 in 2,000 individuals
• Key Keratoconus Companies: Glaukos Corporation, iVeena Delivery Systems, Inc., Cxlusa, Laboratoires Thea, and others
• Key Keratoconus Therapies: Paracel 2 R0185, KXL System, IVMED-80, Riboflavin, T4020, and others
• The Keratoconus epidemiology based on gender analyzed that Keratoconus affects both males and females equally
Get a Free sample for the Keratoconus Market Report
https://www.delveinsight.com/sample-request/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key benefits of the Keratoconus Market report:
1. Keratoconus market report covers a descriptive overview and comprehensive insight of the Keratoconus Epidemiology and Keratoconus market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Keratoconus market report provides insights on the current and emerging therapies.
3. Keratoconus market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Keratoconus market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Keratoconus market.
Download the report to understand which factors are driving Keratoconus epidemiology trends @ Keratoconus Epidemiological Insights
https://www.delveinsight.com/sample-request/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Keratoconus Market
The dynamics of the Keratoconus market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Keratoconus Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Keratoconus Epidemiology Segmentation:
The Keratoconus market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Keratoconus
• Prevalent Cases of Keratoconus by severity
• Gender-specific Prevalence of Keratoconus
• Diagnosed Cases of Episodic and Chronic Keratoconus
Keratoconus Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Keratoconus market or expected to get launched during the study period. The analysis covers Keratoconus market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Keratoconus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Keratoconus market share @ Keratoconus market forecast
https://www.delveinsight.com/sample-request/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Keratoconus Therapies and Key Companies
• Paracel 2 R0185: Glaukos Corporation
• KXL System: Glaukos Corporation
• IVMED-80: iVeena Delivery Systems, Inc.
• Riboflavin: Cxlusa
• T4020: Laboratoires Thea
Keratoconus Market Drivers
• Improvement in treatment and diagnosis options of Keratoconus and a large number of agents show promising activity in Keratoconus
• Environmental factors contribute to the wide variation in prevalence. Geographical locations with plenty of sunshine and hot weather have a higher prevalence than locations with colder climates and less sunlight
Scope of the Keratoconus Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Keratoconus Companies: Glaukos Corporation, iVeena Delivery Systems, Inc., Cxlusa, Laboratoires Thea, and others
• Key Keratoconus Therapies: Paracel 2 R0185, KXL System, IVMED-80, Riboflavin, T4020, and others
• Keratoconus Therapeutic Assessment: Keratoconus current marketed and Keratoconus emerging therapies
• Keratoconus Market Dynamics: Keratoconus market drivers and Keratoconus market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Keratoconus Unmet Needs, KOL's views, Analyst's views, Keratoconus Market Access and Reimbursement
Keratoconus Market Barriers
• Increased public awareness creates a lucrative opportunity for innovation of therapeutics to drive the Keratoconus market
• There is limited approved therapy for Keratoconus, which opens up a huge platform of new therapies to boon the market
• Several agents with novel mechanisms of action are also keenly being reconnoitered in ongoing clinical trials.
Table of Contents
1. Keratoconus Market Report Introduction
2. Executive Summary for Keratoconus
3. SWOT analysis of Keratoconus
4. Keratoconus Patient Share (%) Overview at a Glance
5. Keratoconus Market Overview at a Glance
6. Keratoconus Disease Background and Overview
7. Keratoconus Epidemiology and Patient Population
8. Country-Specific Patient Population of Keratoconus
9. Keratoconus Current Treatment and Medical Practices
10. Keratoconus Unmet Needs
11. Keratoconus Emerging Therapies
12. Keratoconus Market Outlook
13. Country-Wise Keratoconus Market Analysis (2019-2032)
14. Keratoconus Market Access and Reimbursement of Therapies
15. Keratoconus Market Drivers
16. Keratoconus Market Barriers
17. Keratoconus Appendix
18. Keratoconus Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Keratoconus treatment, visit @ Keratoconus Medications
https://www.delveinsight.com/sample-request/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Keratoconus Pipeline https://www.delveinsight.com/report-store/keratoconus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Keratoconus Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Keratoconus market. A detailed picture of the Keratoconus pipeline landscape is provided, which includes the disease overview and Keratoconus treatment guidelines.
Keratoconus Epidemiology https://www.delveinsight.com/report-store/keratoconus-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Keratoconus Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Keratoconus epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports By DelveInsight -
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Keratoconus Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - Glaukos Corporation, iVeena Delivery Systems, Inc., Cxlusa, Laboratoires Thea here
News-ID: 2927144 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for Keratoconus
Valley Optometry Eyecare Center Brings Advanced Keratoconus Treatment to Reseda …
Image: https://www.globalnewslines.com/uploads/2025/09/1758898268.jpg
Valley Optometry Eyecare Center stands as a cornerstone of comprehensive eye care throughout the Greater Los Angeles region. The practice has earned recognition for combining traditional optometric wisdom with modern diagnostic capabilities. Patients from across the San Fernando Valley have come to depend on this facility for everything from basic vision screenings to complex medical interventions that preserve sight.
Keratoconus presents unique challenges that can leave patients feeling hopeless about…
Valley Optometry Eyecare Broadens Awareness Around Reseda Keratoconus Treatment …
Image: https://www.globalnewslines.com/uploads/2025/08/1754401929.jpg
Valley Optometry Eyecare remains a steady presence in the Los Angeles eye care landscape, recognised for its careful, technology-driven approach to diagnosis and long-term treatment. Operating at the intersection of clinical precision and patient accessibility, the centre continues to address lesser-known but increasingly prevalent conditions affecting local vision health.
Among these concerns, keratoconus stands out for its complexity and the subtlety of its onset. Affecting the shape and strength of…
Valley Optometry Eyecare Provides Breakthrough Keratoconus Therapy
Image: https://www.globalnewslines.com/uploads/2025/05/1748342525.jpg
Valley Optometry Eyecare stands at the forefront of advanced eye care for Southern California residents. The practice operates from its central location with modern equipment and highly trained staff ready to tackle complex vision problems. Eye health specialists at this established center work tirelessly to address conditions many patients fear might permanently affect their sight. Valley Optometry Eyecare has earned trust within the community through consistent results and attention…
Keratoconus Treatment Market Size, Share, Trends, Growth and Competitive Analysi …
"Keratoconus Treatment Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. A detailed market research study of this report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as…
Keratoconus Market Size, Share, Trends And Forecast To 2034
How big is the keratoconus market?
The keratoconus market reached a value of US$ 202.1 Million in 2023 and expected to reach US$ 275.0 Million by 2034, exhibiting a growth rate (CAGR) of 2.84% during 2024-2034.
The report offers a comprehensive analysis of the keratoconus market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in…
Keratoconus Market Size, Growth, Research Report & Trends 2023-2033
Keratoconus Market Report Overview:
Report Attribute Details
Base Year …
